Effects of dietary weight loss and exercise on insulin-like growth factor-i and insulin-like growth factor-binding protein-3 in postmenopausal women: A randomized controlled trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 8, 2013, Pages 1457-1463

  Mason, Caitlin ^a   Xiao, Liren ^a   Duggan, Catherine ^a   Imayama, Ikuyo ^a   Foster Schubert, Karen E ^b   Kong, Angela ^c   Campbell, Kristin L ^d   Wang, Ching Yun ^a,b   Alfano, Catherine M ^f   Blackburn, George L ^g   Pollack, Michael ^e   McTiernan, Anne ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^e MCGILL UNIVERSITY   (Canada)

^f NATIONAL CANCER INSTITUTE   (United States)

^g BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AEROBIC EXERCISE; AGED; ARTICLE; BIOAVAILABILITY; BODY MASS; CALORIC RESTRICTION; CANCER RISK; CONTROLLED STUDY; DIET RESTRICTION; DIET THERAPY; FEMALE; HUMAN; INTERVENTION STUDY; MAJOR CLINICAL STUDY; OBESITY; POSTMENOPAUSE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY; THERAPY EFFECT; TREATMENT DURATION; WEIGHT REDUCTION;

AGED; BODY MASS INDEX; CALORIC RESTRICTION; DIET, REDUCING; EXERCISE; FEMALE; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; WEIGHT LOSS;

EID: 84882237923     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0337     Document Type: Article

References (25)

1. Weroha SJ, Haluska P. The insulin-like growth factor system in cancer. Endocrinol Metab Clin North Am 2012;41:335-50.
2. Chen W, Wang S, Tian T, Bai J, Hu Z, Xu Y, et al. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: Evidence from 96 studies. Eur J Hum Genet 2009;17:1668-75.
3. Renehan AG, Frystyk J, Flyvbjerg A. Obesity and cancer risk: The role of the insulin-IGF axis. Trends Endocrinol Metab 2006;17:328-36.
4. Pollak M. Insulin and insulin-like growth factor signalling in neoplasia. Nat Rev 2008;8:915-28.
5. Hursting SD, Smith SM, Lashinger LM, Harvey AE, Perkins SN. Calories and carcinogenesis: Lessons learned from 30 years of calorie restriction research. Carcinogenesis 2010;31:83-9.
6. Dunn SE, Kari FW, French J, Leininger JR, Travlos G, Wilson R, et al. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res 1997;57:4667-72.
7. Sonntag WE, Lynch CD, Cefalu WT, Ingram RL, Bennett SA, Thornton PL, et al. Pleiotropic effects of growth hormone and insulin-like growth factor (IGF)-1 on biological aging: Inferences from moderate caloricrestricted animals. J Gerontol A Biol Sci Med Sci 1999;54:B521-38.
8. Giovannucci E, Pollak M, Liu Y, Platz EA, Majeed N, Rimm EB, et al. Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men. Cancer Epidemiol Biomarkers Prev 2003;12: 84-9.
9. DeLellis K, Rinaldi S, Kaaks RJ, Kolonel LN, Henderson B, Le Marchand L. Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): The multiethnic cohort. Cancer Epidemiol Biomarkers Prev 2004;13:1444-51.
10. Irwin ML, Varma K, Alvarez-Reeves M, Cadmus L, Wiley A, Chung GG, et al. Randomized controlled trial of aerobic exercise on insulin and insulin-like growth factors in breast cancer survivors: The Yale Exercise and Survivorship study. Cancer Epidemiol Biomarkers Prev 2009;18: 306-13.
11. Calle E, Kaaks R. Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms. Nat Rev 2004;4:579-91.
12. Kaaks R, Lukanova A. Energy balance and cancer: The role of insulin and insulin-like growth factor-I. Proc Nutr Soc 2001;60:91-106.
13. Frystyk J. Free insulin-like growth factors-measurements and relationships to growth hormone secretion and glucose homeostasis. Growth Horm IGF Res 2004;14:337-75.
14. Foster-Schubert KE, Alfano CM, Duggan C, Xiao L, Campbell KL, Kong A, et al. Effect of diet and exercise, alone or combined, on weight and body composition in overweight-to-obese postmenopausal women. Obesity 2011;20:1628-38.
15. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346: 393-403.
16. Ryan DH, Espeland MA, Foster GD, Haffner SM, Hubbard VS, Johnson KC, et al. Look AHEAD (Action for Health in Diabetes): Design and methods for a clinical trial of weight loss for the prevention of cardiovascular disease in type 2 diabetes. Control Clin Trials 2003;24: 610-28.
17. Rogozina OP, Bonorden MJ, Grande JP, Cleary MP. Serum insulin-like growth factor-I and mammary tumor development in ad libitum-fed, chronic calorie-restricted, and intermittent calorie-restricted MMTVTGF-alpha mice. Cancer Prev Res 2009;2:712-9.
18. Dogan S, Johannsen AC, Grande JP, Cleary MP. Effects of intermittent and chronic calorie restriction on mammalian target of rapamycin (mTOR) and IGF-I signaling pathways in mammary fat pad tissues and mammary tumors. Nutr Cancer 2011;63:389-401.
19. Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Kocelak P, Janowska J, Semik-Grabarczyk E. The effect of weight reduction on plasma concentrations of ghrelin and insulin-like growth factor 1 in obese women. Polish J Endocrinol 2008;59:301-4.
20. Lien LF, Haqq AM, Arlotto M, Slentz CA, Muehlbauer MJ, McMahon RL, et al. The STEDMAN project: Biophysical, biochemical and metabolic effects of a behavioral weight loss intervention during weight loss, maintenance, and regain. OMICS 2009;13:21-35.
21. Harvie M, Renehan AG, Frystyk J, Flyvbjerg A, Mercer T, Malik R, et al. Increase in serum total IGF-1 and maintenance of free IGF-1 following intentional weight loss in premenopausal women at increased risk of breast cancer. Open Obes J 2010;2:63-70.
22. Kaaks R, Bellati C, Venturelli E, Rinaldi S, Secreto G, Biessy C, et al. Effects of dietary intervention on IGF-I and IGF-binding proteins, and related alterations in sex steroid metabolism: The Diet and Androgens (DIANA) Randomised Trial. Eur J Clin Nutr 2003;57:1079-88.
23. Harvie MN, Pegington M, Mattson MP, Frystyk J, Dillon B, Evans G, et al. The effects of intermittent or continuous energy restriction on weight loss and metabolic disease risk markers: A randomized trial in young overweight women. Int J Obes 2011;35:714-27.
24. Frystyk J. Utility of free IGF-I measurements. Pituitary 2007;10:181-7.
25. Berrigan D, Potischman N, Dodd KW, Hursting SD, Lavigne J, Barrett JC, et al. Race/ethnic variation in serum levels of IGF-I and IGFBP-3 in US adults. Growth Horm IGF Res 2009;19:146-55.